Fig. 1.
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) are approved as a first-line treatment for advanced non-small cell lung cancer harboring EGFR mutation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.